Jefferies
Jefferies Initiates Coverage of NeoGenomics, Hologic, QuidelOrtho
The investment bank said it prefers diagnostics companies with strong commercial engines, although noted it that Hologic and QuidelOrtho are in transition.
Diagnostics Firm Quotient Nets $64.6M From Public Offering
The company also said that it received ISO 13485:2016 certification for its Mosaiq platform and it has filed for CE marking for its initial immunohematology microarray.